SCHEMBL7500825

SCHEMBL7500825

NS(=O)(=O)c1ccc(-c2nc(Cc3ccccc3)oc2-c2ccccc2Cl)cc1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NR4A2 P43354 5/20 0.55
▸ RXRA P19793 4/20 0.53
▸ RXRB P28702 4/20 0.53
▸ CA1 P00915 6/20 0.51
▸ CA2 P00918 6/20 0.51
▸ PTGS2 P35354 6/20 0.48
▸ PTGS1 P23219 3/20 0.48
▸ NR4A1 P22736 1/20 0.48
▸ NR4A3 Q92570 1/20 0.48
▸ CA12 O43570 2/20 0.48
▸ CA9 Q16790 2/20 0.48
▸ CA14 Q9ULX7 1/20 0.48
▸ RXRG P48443 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ MAOA P21397 1/20 0.40
▸ MAOB P27338 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7513361 0.91 NR4A2 (0.53) NR4A2RXRARXRBCA1CA2
SCHEMBL7499042 0.91 NR4A2 (0.45) NR4A2RXRARXRBCA1CA2
SCHEMBL7503365 0.89 RXRA (0.56) NR4A2RXRARXRBCA1CA2
SCHEMBL7509654 0.89 RXRA (0.46) NR4A2RXRARXRBCA1CA2
SCHEMBL7508608 0.89 CA1 (0.48) NR4A2RXRARXRBCA1CA2
SCHEMBL7511828 0.89 NR4A2 (0.55) NR4A2RXRARXRBPTGS2PTGS1
SCHEMBL7505716 0.88 NR4A2 (0.43) NR4A2RXRARXRBCA1CA2
SCHEMBL7507875 0.88 CA1 (0.43) NR4A2RXRARXRBCA1CA2
SCHEMBL7511649 0.87 CA1 (0.48) NR4A2CA1CA2PTGS2PTGS1
SCHEMBL7504402 0.87 RXRA (0.53) NR4A2RXRARXRBCA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0699192-B1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2002-07-24 — — EP disclosed
US-6090834-A ANALGESICS; RHEUMATIC DISORDERS; SKIN DISORDERS; GASTROINTESTINAL DISORDERS G.D. SEARLE & CO. (US) 2000-07-18 — — US disclosed
EP-0825989-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1998-03-04 — — EP disclosed
WO-1996036617-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-11-21 — — WO disclosed
EP-0699192-A1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-03-06 — — EP disclosed
WO-1994027980-A1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1994-12-08 — — WO disclosed
Send feedback